Artwork

Content provided by The Bench Report UK. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bench Report UK or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Rare Cancers: A Bill of Hope and the Fight for Fair Treatment

17:51
 
Share
 

Manage episode 472950681 series 3654608
Content provided by The Bench Report UK. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bench Report UK or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

This episode of 'The Bench Report' delves into the passionate and moving debate surrounding the Rare Cancers Bill, a crucial piece of legislation aiming to address the disparities faced by individuals diagnosed with less common cancers.

Discover why so-called "rare" cancers collectively account for nearly half of all cancer diagnoses and over half of cancer-related deaths, yet often receive disproportionately less attention and funding.

We explore the key measures of the Bill and the overwhelming cross-party support for its potential to transform the lives of patients and their families, offering a beacon of hope in the face of devastating diseases like glioblastoma, pancreatic cancer, and rare childhood cancers.

Key Takeaways:

  • "Rare" cancers are collectively common, representing a significant portion of all cancer diagnoses and deaths.
  • Patients with rare cancers often face delayed diagnosis due to a lack of awareness and familiarity with their symptoms.
  • There is a significant lack of research and development in rare cancer treatments compared to more common cancers, leading to poorer survival rates.
  • Access to clinical trials is limited for rare cancer patients, with a large percentage not even being offered the opportunity to participate.
  • The Rare Cancers Bill aims to appoint a national specialty lead for rare cancer research.
  • The Bill proposes creating single registries for rare cancer trials and patients to improve accessibility and recruitment.
  • A key aspect of the Bill is to review the orphan drug regulations to better incentivize pharmaceutical companies to invest in rare cancer treatments and drug repurposing.
  • The debate highlighted the urgent need for action and a more revolutionary attitude towards tackling rare cancers.

Read the extended shownotes on Substack.

Source: Rare Cancers Bill (Hansard)

Support the show

Follow and subscribe to 'The Bench Report' on Apple Podcasts, Spotify, and YouTube for new episodes on weekdays: thebenchreport.co.uk

Extended shownotes for selected episodes can be found at: thebenchreport.substack.com

Shape our next episode! Get in touch with an issue important to you - Producer Tom will grab another coffee and start the research!

Email us: [email protected]

Follow us on YouTube, X, Bluesky, Facebook and Instagram @BenchReportUK

Support us for bonus episodes and more.

No outside chatter: source material only taken from Hansard and the Parliament UK website.

Contains Parliamentary information repurposed under the Open Parliament Licence v3.0.

  continue reading

51 episodes

Artwork
iconShare
 
Manage episode 472950681 series 3654608
Content provided by The Bench Report UK. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bench Report UK or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

This episode of 'The Bench Report' delves into the passionate and moving debate surrounding the Rare Cancers Bill, a crucial piece of legislation aiming to address the disparities faced by individuals diagnosed with less common cancers.

Discover why so-called "rare" cancers collectively account for nearly half of all cancer diagnoses and over half of cancer-related deaths, yet often receive disproportionately less attention and funding.

We explore the key measures of the Bill and the overwhelming cross-party support for its potential to transform the lives of patients and their families, offering a beacon of hope in the face of devastating diseases like glioblastoma, pancreatic cancer, and rare childhood cancers.

Key Takeaways:

  • "Rare" cancers are collectively common, representing a significant portion of all cancer diagnoses and deaths.
  • Patients with rare cancers often face delayed diagnosis due to a lack of awareness and familiarity with their symptoms.
  • There is a significant lack of research and development in rare cancer treatments compared to more common cancers, leading to poorer survival rates.
  • Access to clinical trials is limited for rare cancer patients, with a large percentage not even being offered the opportunity to participate.
  • The Rare Cancers Bill aims to appoint a national specialty lead for rare cancer research.
  • The Bill proposes creating single registries for rare cancer trials and patients to improve accessibility and recruitment.
  • A key aspect of the Bill is to review the orphan drug regulations to better incentivize pharmaceutical companies to invest in rare cancer treatments and drug repurposing.
  • The debate highlighted the urgent need for action and a more revolutionary attitude towards tackling rare cancers.

Read the extended shownotes on Substack.

Source: Rare Cancers Bill (Hansard)

Support the show

Follow and subscribe to 'The Bench Report' on Apple Podcasts, Spotify, and YouTube for new episodes on weekdays: thebenchreport.co.uk

Extended shownotes for selected episodes can be found at: thebenchreport.substack.com

Shape our next episode! Get in touch with an issue important to you - Producer Tom will grab another coffee and start the research!

Email us: [email protected]

Follow us on YouTube, X, Bluesky, Facebook and Instagram @BenchReportUK

Support us for bonus episodes and more.

No outside chatter: source material only taken from Hansard and the Parliament UK website.

Contains Parliamentary information repurposed under the Open Parliament Licence v3.0.

  continue reading

51 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play